Call Protection: NC2-3 (50%, 25%, Par). MWC at B+50bp. Equity claw: 40% up to 3 years. Special call: 10% per year for the first 2 years at 103.
Use of Proceeds: Along with proceeds from equity contribution, and a USD/EUR term loan B 2-part (US$500m minimum and €500m minimum) (total loan and bond deal size CHF1.38bn equivalent), to fund the CHF2bn purchase price for the acquisition of a 60% interest in Capsugel by Lone Star from Lonza Group AG (which will retain a 40% minority interest) and provide for cash overfunding to the balance sheet.
Joint Global Coordinators and Physical Bookrunners: GS (B&D), Jefferies, BNP, and UBS
Joint Bookrunners: BBVA, ING, IMI - Intesa Sanpaolo, RBI, SocGen, UniCredit, and Standard Chartered
Listing: ISE
Governing Law: NY Law
Denominations: €100k x €1k
Equity Sponsor: Lone Star
Equity Contribution: CHF823m, including Lonza's rollover equity.
Roadshow (virtual meetings): Started 27-Apr-26
Global Investor Call: 15:00 UKT / 10:00 ET 27-Apr-26